SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-266134
Filing Date
2021-09-07
Accepted
2021-09-07 09:28:41
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d328142ds3.htm S-3 401515
2 EX-1.2 d328142dex12.htm EX-1.2 190873
3 EX-4.5 d328142dex45.htm EX-4.5 284221
4 EX-5.1 d328142dex51.htm EX-5.1 13430
5 EX-23.1 d328142dex231.htm EX-23.1 1283
6 GRAPHIC g328142g04h75.jpg GRAPHIC 39512
  Complete submission text file 0001193125-21-266134.txt   946878
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-259353 | Film No.: 211238455
SIC: 2836 Biological Products, (No Diagnostic Substances)